Lexicon Pharmaceuticals | Ventas

Sales Cambio Fecha
Abbott USD 9.96B 281M 2024-03
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 8.19M 1.09M 2024-03
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
AstraZeneca USD 12.02B 532M 2023-12
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Eli Lilly USD 8.77B 583.4M 2024-03
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Illumina USD 1.08B 42M 2024-03
Insmed USD 83.69M 4.62M 2023-12
Ironwood Pharmaceuticals USD 117.55M 3.81M 2023-12
J&J USD 21.38B 15M 2024-03
MacroGenics USD 10.72M 323K 2023-12
MannKind USD 58.47M 7.22M 2023-12
Merck USD 15.8B 1.17B 2024-03
Moderna USD 167B 164.19B 2024-03
Novartis USD 11.83B 54M 2024-03
PTC Therapeutics USD 210.12M 96.94M 2024-03
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
Thermo Fisher Scientific USD 10.34B 546M 2024-03
Ultragenyx Pharmaceutical USD 108.8M 18.59M 2024-03
United Therapeutics USD 677.7M 63M 2024-03



Lexicon Pharmaceuticals Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2024.